NCT00702585View on ClinicalTrials.gov

Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016)

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 1, 2001

Primary Completion Date

October 15, 2002

Study Completion Date

October 15, 2002

Conditions
Infertility
Interventions
DRUG

Org 36286

Org 36286 single-dose subcutaneous injection

DRUG

Placebo

Placebo to Org 36286 as a single-dose subcutaneous injection

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00702585 - Study to Investigate the Optimal Dose of Org 36286 to Induce Monofollicular Ovulation in Women With WHO Group II Anovulatory Infertility (P07016) | Biotech Hunter | Biotech Hunter